SCHEMBL17664338

SCHEMBL17664338

Cc1cccc(CNC(=O)N/C=C/c2cccc(C(F)(F)F)c2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDT P30046 1/20 0.53
▸ HTT P42858 2/20 0.49
▸ NFE2L2 Q16236 1/20 0.48
▸ KDM4E B2RXH2 2/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.47
▸ MAOA P21397 1/20 0.46
▸ MAOB P27338 1/20 0.46
▸ MLYCD O95822 1/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ PLA2G1B P04054 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ ATG4B Q9Y4P1 1/20 0.46
▸ LMNA P02545 3/20 0.45
▸ ALDH1A1 P00352 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17664233 0.93 MLYCD (0.53) KDM4ENPSR1MLYCDMEN1KMT2A
SCHEMBL23447432 0.85 MLYCD (0.58) DDTKDM4ENPSR1MLYCDMEN1
SCHEMBL17664337 0.84 LMNA (0.51) HTTNPSR1MAOAMAOBMEN1
SCHEMBL17664237 0.81 CNR1 (0.58) HTTKDM4ENPSR1MAOAMAOB
SCHEMBL17664230 0.80 LMNA (0.52) MEN1KMT2AGAAATG4BLMNA
SCHEMBL23447438 0.80 SMN1; SMN2 (0.68) DDTHTTMEN1KMT2ALMNA
SCHEMBL17664339 0.79 PTPN1 (0.41) DDTHTTCYP1A2CYP3A4CYP2C19
SCHEMBL17664223 0.77 ATG4B (0.49) KDM4ENPSR1MAOAMAOBMLYCD
SCHEMBL24713109 0.77 MLYCD (0.67) KDM4ENPSR1MLYCDMEN1KMT2A
SCHEMBL17664299 0.76 HTT (0.60) HTTKDM4ENPSR1MAOBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016049774-A1 UREA AND BIS-UREA BASED COMPOUNDS AND ANALOGUES THEREOF USEFUL IN THE TREATMENT OF ANDROGEN RECEPTOR MEDIATED DISEASES OR DISORDERS THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2016-04-07 — — WO disclosed
Send feedback